NPPA and Hypertension: Monoclonal antibodies against ANP were often used to block the endogenous action of ANP in spontaneously hypertensive rats (SHR), which resulted in accelerated development of hypertension in these animals compared with Wistar Kyoto (WKY) rats [95].